Tower Research Capital (TRC)’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-1,103
Closed -$108K 5680
2015
Q1
$108K Buy
1,103
+1,080
+4,696% +$106K 0.01% 826
2014
Q4
$2K Sell
23
-25
-52% -$2.17K ﹤0.01% 3534
2014
Q3
$3K Buy
+48
New +$3K ﹤0.01% 3722
2014
Q2
Sell
-29
Closed -$2K 5287
2014
Q1
$2K Buy
+29
New +$2K ﹤0.01% 4026
2013
Q4
Sell
-2,337
Closed -$148K 5315
2013
Q3
$148K Buy
2,337
+1,353
+138% +$85.7K 0.02% 975
2013
Q2
$41K Buy
+984
New +$41K ﹤0.01% 1103